EXPRESSION OF IMMUNOGLOBULIN SEQUENCES HOMOLOGOUS TO ANTI-SARS-CoV-2 ANTIBODIES AND HIV IN CHRONIC LYMPHOCYTIC LEUKEMIA CASES

Authors

  • I. Abramenko National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine
  • N. Bilous National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine
  • A. Chumak National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine
  • Z. Martina National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine
  • I. Dyagil National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine
  • D. Bazyka National Research Center for Radiation Medicine, National Academy of Medical Sciences of Ukraine

DOI:

https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18414

Keywords:

chronic lymphocytic leukemia, immunoglobulin variable heavy chain (IGHV) gene, SARS-CoV-2 antibodies

Abstract

Background: Identification of epitopes recognized by leukemic B cells could provide insights into the molecular mechanisms of B cell transformation in chronic lymphocytic leukemia (CLL). The aim of this paper was to compare nucleotide sequences of immunoglobulin heavy chain variable region (IGHV) genes in CLL with known sequences directed against antigens of different origins available in public databases. Materials and Methods: Analysis was performed in the groups of 412 unselected CLL patients with productive IGHV gene using polymerase chain reaction followed by direct sequencing. Results: Homology between CLL Ig sequences and antibodies directed against autoantigens was found in 12 patients (2.9%), homology between CLL Ig sequences and antiviral antibodies — in 35 patients (8.5%). Most of these sequences belonged to stereotypical clusters. Among the sequences that have homology to antiviral antibodies, the most prevalent were cases homologous with antibodies against HIV (14 cases, 3.4%) and SARS-CoV-2 antigens (10 cases, 2.4%). None of the patients in our cohort was HIV-infected and the study was conducted before the emergence of SARS-CoV-2 virus. Conclusions: Suggestions could be made about the possible impact of past infection of SARS-CoV-2 virus on the pathogenesis of CLL. In particular, an increase in the proportion of CLL cases with the expression of some stereotyped BCR and/or an increase of CLL risk in the long-term period after SARS-CoV-2 virus infection is not excluded. This assumption needs to be verified by epidemiological data.

References

Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101: 4952‒7. https://doi.org/10.1182/blood-2002-11-3485

Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004; 113: 1008‒16. https://doi.org/10.1172/JCI19399.

Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519‒25. https://doi.org/10.1084/jem.20040544

Agathangelidis A, Darzentas N, Hadzidimitriou A, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012; 119: 4467‒75. https://doi.org/10.1182/blood-2011-11-393694

Chiorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011; 117: 1781‒91. https://doi.org/10.1182/blood-2010-07-155663.

Kostareli E, Gounari M, Agathangelidis A, Stamatopoulos K. Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions. Mediterr J Hematol Infect Dis 2012; 4: e2012052. https://doi.org/10.4084/MJHID.2012.052.

Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219‒34.

Rai KR. A critical analysis of staging in CLL. In: Gale RP, Rai KR, eds. CLL recent progress and future directions, vol. 59. UCLA Symposia on Molecular and Cellular Biology. New York: Alan R. Liss; 1987. 253 p.

Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981, 48; 198‒206. https://doi.org/10.1002/ 1097-0142(19810701) 48:1<198::aid-cncr2820480131>3.0.co;2-v

Abramenko I, Bilous N, Chumak A, et al. Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident–with focus on immunoglobulin heavy chain gene analysis. Leuk Res 2008; 32: 535‒45. https://doi.org/10.1016/j.leukres.2007.08.013

Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848‒54. PMID: 10477713

Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840‒7. PMID: 10477712

Agathangelidis A, Chatzidimitriou A, Gemenetzi K, et al. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood 2021; 137: 1365‒76. https://doi.org/10.1182/blood.2020007039

Austin JW, Buckner CM, Kardava L, et al. Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation. Sci Transl Med 2019; 11: eaax0904. https://doi.org/10.1126/scitranslmed.aax0904

Sakharkar M, Rappazzo CG, Wieland-Alter WF, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol 2021; 6: eabg6916. https://doi.org/10.1126/sciimmunol.abg6916

Jennewein MF, MacCamy AJ, Akins NR, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep 2021; 36: 109353. https://doi.org/10.1016/j.celrep.2021.109353

Wang Z, Lorenzi JCC, Muecksch F, et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med 2021; 13: eabf1555. https://doi.org/10.1126/scitranslmed.abf1555.

Li D, Edwards RJ, Manne K, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell 2021, 184:4203‒19.e32. https://doi.org/10.1016/j.cell.2021.06.021

Amanat F, Thapa M, Lei T, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 2021; 184: 3936‒48.e10. https://doi.org/10.1016/j.cell.2021.06.005

Chen EC, Gilchuk P, Zost SJ, et al. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Rep 2021; 36: 109604. https://doi.org/10.1016/j.celrep.2021.109604

Turner JS, O’Halloran JA, Kalaidina E, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 2021; 596: 109‒13. https://doi.org/10.1038/s41586-021-03738-2

Chu CC, Catera R, Zhang L, et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 2010; 115: 3907–15. https://doi.org/10.1182/blood-2009-09-244251

Binder M, Lechenne B, Ummanni R, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells. PLoS One 2010; 5: e15992. https://doi.org/10.1371/journal.pone.0015992

Hwang KK, Trama AM, Kozink DM, et al. IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria. PLoS One 2014; 9: e90725. https://doi.org/10.1371/journal.pone.0090725

Que X, Widhopf GF 2nd, Amir S, et al. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. PLoS One 2013; 8: e65203. https://doi.org/10.1371/journal.pone.0065203

Kim SI, Noh J, Kim S, et al. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med 2021; 13: eabd6990. https://doi.org/10.1126/scitranslmed.abd6990

WHO (World Health Organization). Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Updated on 7:41pm CEST, 18 May 2022. Accessed 19 May 2022.

Gluzman DF, Zavelevich MP, Philchenkov AA, et al. Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects. Exp Oncol 2021; 43: 189–92. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16434

Gluzman DF, Zavelevich MP, Philchenkov AA, et al. Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era. Exp Oncol 2021; 43: 87–91. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15795

Downloads

Published

26.05.2023

How to Cite

Abramenko, I., Bilous, N., Chumak, A., Martina, Z., Dyagil, I., & Bazyka, D. (2023). EXPRESSION OF IMMUNOGLOBULIN SEQUENCES HOMOLOGOUS TO ANTI-SARS-CoV-2 ANTIBODIES AND HIV IN CHRONIC LYMPHOCYTIC LEUKEMIA CASES. Experimental Oncology, 44(3), 208–212. https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18414

Issue

Vol. 44 No. 3 (2022): Experimental Oncology

Section

Original contributions

License

Copyright (c) 2023 Experimental Oncology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)